MedPath

A Phase 2 Study of Pemetrexed in Patients with Previously Treated Non-Squamous Non-Small-Cell Lung Cancer

Phase 2
Conditions
Previously treated non-squamous non-small cell lung cancer
Registration Number
JPRN-UMIN000002467
Lead Sponsor
Kobe Lung Cancer Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of drug induced interstitial pneumonia 3)History of severe drug allergy 4)History of active infection or other serious disease condition (GI bleeding,etc.) 5)History of poorly controlled pleural effusion,pericardial effusion and ascites 6)History of severe heart disease(uncontrollable arrythmia,uncontrollable angina pectoris,herat failure,etc.) 7)Uncontrollable diabetes mellitus 8)History of symptomatic brain metastases 9)Hystory of active double cancer 10)History of active psychological disease 11)History of pregnancy or lactation 12)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath